Adding oxygen to enhance antibiotic treatment of chronic lung infection

2024-513197-22-02 Human pharmacology (Phase I) - Other Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruitment pending
Participants planned 10
Countries 1
Sites 1

Primary ciliary dyskinesia

Key facts

Sponsor
Rigshospitalet
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Respiratory Tract Diseases [C08], Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02], Diseases [C] - Bacterial Infections and Mycoses [C01]
Decision date (initial)
2024-09-13
Transition trial
No
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

External identifiers

EU CT number
2024-513197-22-02
WHO UTN
U1111-1303-6004

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Primary ciliary dyskinesia

VersionLevelCodeTermSystem organ class
20.0 PT 10069713 Primary ciliary dyskinesia 100000004850
20.0 PT 10011762 Cystic fibrosis 100000004850
22.1 LLT 10035691 Pneumonia due to pseudomonas 10021881

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Rigshospitalet

Sponsor organisation
Rigshospitalet
Address
Blegdamsvej 9
City
Copenhagen Oe
Postcode
2100
Country
Denmark

Scientific contact point

Organisation
Rigshospitalet
Contact name
Tavs Qvist

Public contact point

Organisation
Rigshospitalet
Contact name
Tavs Qvist

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Denmark Authorised, recruitment pending 10 1
Rest of world 0

Investigational sites

Denmark

1 site · Authorised, recruitment pending
Rigshospitalet
Department of Infectiuos Diseseases, Blegdamsvej 9, 2100, Copenhagen Oe

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-06-11 Denmark Acceptable
2024-09-13
2024-09-13